Drug intelligence / Profile preview

Eldervit-12

Development stage
Unknown
Lead developer
Elder Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Eldervit-12 is a multivitamin combination product containing folic acid, methylcobalamin (Vitamin B12), niacinamide (Vitamin B3), and ascorbic acid (Vitamin C). It is primarily indicated for the treatment of nutritional deficiencies, megaloblastic anemia, and peripheral neuropathy. The components function as essential cofactors in various metabolic pathways: folic acid and methylcobalamin are critical for DNA synthesis and red blood cell production, specifically involving enzymes like 5,10-methylenetetrahydrofolate reductase and methionine synthase. Niacinamide acts as a precursor to the coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital for cellular respiration and energy metabolism. Ascorbic acid serves as a potent antioxidant that scavenges free radicals and is a necessary cofactor for collagen synthesis. Originally developed by Elder Pharmaceuticals, the brand was acquired by Torrent Pharmaceuticals for the Indian and Nepalese markets.

Brand names
Eldervit-12Eldervit12Eldervit 12Eldervit
Other names
folic acid + methylcobalamin + niacinamide + ascorbic acid
02

Targets

MTR (Methionine synthase)MTHFR (Methylenetetrahydrofolate reductase)

Beyond the preview

Go deeper on Eldervit-12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eldervit-12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call